Abstract
Mycobacterium tuberculosis, the causative factor of tuberculosis (TB) infections, has an atypical outer membrane mostly consisting of lipids with long-chain and branched fatty acids termed mycolic acids. These lipids establish a permeability barrier that inhibits numerous environmental solutes from entering the bacteria, making them acid-fast and enabling them to thrive in harsh environments. To meet their target, anti-TB drugs need to penetrate this layer. This review focuses on drug development initiatives that have contributed to TB drug development, lipids’ roles in M. tuberculosis pathogenesis, and recently made fresh remarkable progress in developing novel lead chemical compounds that target their biosynthesis metabolisms. Selective bacterial membrane targeting as a promising therapeutic approach against persistent infectious diseases such as TB has been proposed in this review study.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Basic Science in Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.